Detalhe da pesquisa
1.
Histopathological diagnosis of cutaneous melanocytic lesions: blinded and nonblinded second opinions offer similar improvement in diagnostic accuracy.
Clin Exp Dermatol
; 47(9): 1658-1665, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426450
2.
Combining biomarkers by maximizing the true positive rate for a fixed false positive rate.
Biom J
; 63(6): 1223-1240, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33871887
3.
Statistical inference for net benefit measures in biomarker validation studies.
Biometrics
; 76(3): 843-852, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732971
4.
Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs.
Breast Cancer Res Treat
; 167(1): 195-203, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28879558
5.
Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.
J Am Acad Dermatol
; 79(1): 52-59.e5, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29524584
6.
Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?
Ann Surg Oncol
; 24(5): 1234-1241, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27913946
7.
Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective.
Ann Intern Med
; 164(10): 649-55, 2016 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26999810
8.
Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?
Clin Chem
; 62(5): 737-42, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001493
9.
Designing a study to evaluate the benefit of a biomarker for selecting patient treatment.
Stat Med
; 34(27): 3503-15, 2015 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26112650
10.
Diagnostic concordance among pathologists interpreting breast biopsy specimens.
JAMA
; 313(11): 1122-32, 2015 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25781441
11.
Net reclassification indices for evaluating risk prediction instruments: a critical review.
Epidemiology
; 25(1): 114-21, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240655
12.
The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.
Clin Chem
; 59(1): 68-74, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23193062
13.
When does combining markers improve classification performance and what are implications for practice?
Stat Med
; 32(11): 1877-92, 2013 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23348801
14.
Testing for improvement in prediction model performance.
Stat Med
; 32(9): 1467-82, 2013 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23296397
15.
Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS).
BMC Womens Health
; 13: 3, 2013 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23379630
16.
Estimating improvement in prediction with matched case-control designs.
Lifetime Data Anal
; 19(2): 170-201, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23358916
17.
Adopting nested case-control quota sampling designs for the evaluation of risk markers.
Lifetime Data Anal
; 19(4): 568-88, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23807695
18.
Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context.
Am J Epidemiol
; 176(6): 482-7, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875756
19.
Estimating the diagnostic likelihood ratio of a continuous marker.
Biostatistics
; 12(1): 87-101, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20639522
20.
Biases introduced by choosing controls to match risk factors of cases in biomarker research.
Clin Chem
; 58(8): 1242-51, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22730452